Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

139.01 -0.17 (-0.12%)
Streaming Delayed Price Updated: 3:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 525,116
Open 138.86
Bid (Size) 138.99 (600)
Ask (Size) 139.02 (100)
Prev. Close 139.18
Today's Range 138.84 - 139.45
52wk Range 96.91 - 140.18
Shares Outstanding N/A
Dividend Yield 2.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme... 
Via MarketMinute
Topics ETFs Intellectual Property
News headline image
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case ↗
Novartis (NVS) presents a classic value investing case: a financially strong pharmaceutical leader trading at a discount to peers, with high profitability and a solid dividend. 
Via Chartmill

Performance

YTD
+43.1%
+43.1%
1 Month
+6.6%
+6.6%
3 Month
+12.0%
+12.0%
6 Month
+14.9%
+14.9%
1 Year
+42.8%
+42.8%

More News

Read More
News headline image
The Biological Turing Point: How AlphaFold 3 and the Nobel Prize Redefined the Future of Medicine
Via TokenRing AI
Topics Artificial Intelligence Initial Public Offering
News headline image
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill ↗
Via The Motley Fool
Topics Stocks
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
2 Top Stocks to Buy and Hold for the Long Term ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗
Via Investor's Business Daily
Topics Government Stocks
News headline image
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
Via Stocktwits
Topics Economy Government
News headline image
White House Readies Drug Price Deals With AbbVie, Novartis, Roche ↗
Via Benzinga
News headline image
Salesforce Stock Rises On BTIG Buy Rating And Novartis Agentforce Deal ↗
Via Benzinga
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
Via Stocktwits
Topics Government World Trade
News headline image
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials ↗
Via Chartmill
News headline image
Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder ↗
Via Benzinga
News headline image
Silver Shines as Global Tariff Storm Gathers: A Safe-Haven and Strategic Imperative in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Can the Vanguard International High Dividend Yield Index Fund ETF Shares Outperform Again in 2026? ↗
Via The Motley Fool
Topics ETFs Economy Stocks
News headline image
Is Alnylam Pharmaceuticals a Millionaire Maker? ↗
Via The Motley Fool
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny
Via MarketMinute
Topics Intellectual Property
News headline image
Janux Therapeutics Stock Sinks 50% After Prostate Cancer Trial Triggers Target Cuts Across Wall Street — Retail Sees A FOMO-Fueled Rebound ↗
Via Stocktwits
News headline image
1 No-Brainer International Vanguard ETF to Buy Right Now for Less Than $100 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
2 High-Yielding ETFs That Can Bankroll Your Retirement for Years ↗
Via The Motley Fool
Topics ETFs Economy Retirement
News headline image
Why Novartis Stock Topped the Market Today ↗
Via The Motley Fool
News headline image
FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults ↗
Via Benzinga
News headline image
Novartis Stock Rises Premarket After FDA Approves First Gene Therapy For Teens And Adults With Muscle-Weakening Disorder ↗
Via Stocktwits

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 139.01
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 12/29/25 03:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.